Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

SARS-CoV-2 T cell responses are expected to remain robust against Omicron

View ORCID ProfileSyed Faraz Ahmed, View ORCID ProfileAhmed Abdul Quadeer, View ORCID ProfileMatthew R. McKay
doi: https://doi.org/10.1101/2021.12.12.472315
Syed Faraz Ahmed
1Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong SAR, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Syed Faraz Ahmed
Ahmed Abdul Quadeer
1Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong SAR, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ahmed Abdul Quadeer
  • For correspondence: matthew.mckay@unimelb.edu.au eeaaquadeer@ust.hk
Matthew R. McKay
3Department of Electrical and Electronic Engineering, University of Melbourne, Melbourne, Victoria, Australia
4Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
1Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong SAR, China
2Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong SAR, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew R. McKay
  • For correspondence: matthew.mckay@unimelb.edu.au eeaaquadeer@ust.hk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2021.12.12.472315
History 
  • December 14, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Syed Faraz Ahmed1,#,
  2. Ahmed Abdul Quadeer1,#,* and
  3. Matthew R. McKay3,4,1,2,*
  1. 1Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong SAR, China
  2. 2Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong SAR, China
  3. 3Department of Electrical and Electronic Engineering, University of Melbourne, Melbourne, Victoria, Australia
  4. 4Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
  1. ↵*Correspondence: Matthew R. McKay (matthew.mckay{at}unimelb.edu.au) and Ahmed Abdul Quadeer (eeaaquadeer{at}ust.hk).
  1. ↵# These authors contributed equally

Back to top
PreviousNext
Posted December 14, 2021.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 T cell responses are expected to remain robust against Omicron
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 T cell responses are expected to remain robust against Omicron
Syed Faraz Ahmed, Ahmed Abdul Quadeer, Matthew R. McKay
bioRxiv 2021.12.12.472315; doi: https://doi.org/10.1101/2021.12.12.472315
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 T cell responses are expected to remain robust against Omicron
Syed Faraz Ahmed, Ahmed Abdul Quadeer, Matthew R. McKay
bioRxiv 2021.12.12.472315; doi: https://doi.org/10.1101/2021.12.12.472315

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Immunology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4844)
  • Biochemistry (10777)
  • Bioengineering (8034)
  • Bioinformatics (27256)
  • Biophysics (13963)
  • Cancer Biology (11110)
  • Cell Biology (16026)
  • Clinical Trials (138)
  • Developmental Biology (8772)
  • Ecology (13268)
  • Epidemiology (2067)
  • Evolutionary Biology (17341)
  • Genetics (11678)
  • Genomics (15903)
  • Immunology (11013)
  • Microbiology (26044)
  • Molecular Biology (10625)
  • Neuroscience (56458)
  • Paleontology (417)
  • Pathology (1729)
  • Pharmacology and Toxicology (2999)
  • Physiology (4539)
  • Plant Biology (9614)
  • Scientific Communication and Education (1613)
  • Synthetic Biology (2683)
  • Systems Biology (6967)
  • Zoology (1508)